2019
DOI: 10.2174/1389203720666190208110416
|View full text |Cite
|
Sign up to set email alerts
|

Biotechnological Applications of Protein Splicing

Abstract: Protein splicing domains, also called inteins, have become a powerful biotechnological tool for applications involving molecular biology and protein engineering. Early applications of inteins focused on self-cleaving affinity tags, generation of recombinant polypeptide α-thioesters for the production of semisynthetic proteins and backbone cyclized polypeptides. The discovery of naturallyoccurring split-inteins has allowed the development of novel approaches for the selective modification of proteins b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
31
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(31 citation statements)
references
References 179 publications
0
31
0
Order By: Relevance
“…Recent AAV technological advances are under preclinical investigation and are being considered for clinical development. This technology includes dual AAV 53–55 and triple AAV, 56 in which case, a large transgene is split into 2 or 3 separate vectors to ultimately reconstitute to a full-length gene, as well as intein-mediated protein trans-splicing, 57 which reconstitute large proteins from shorter precursor polypeptides (separately encoded by 2 or more independent AAV vectors). Although convincible preclinical data have been generated through subretinal administration, 58 these platforms have not yet been assessed by the SC route.…”
Section: Future Directionsmentioning
confidence: 99%
“…Recent AAV technological advances are under preclinical investigation and are being considered for clinical development. This technology includes dual AAV 53–55 and triple AAV, 56 in which case, a large transgene is split into 2 or 3 separate vectors to ultimately reconstitute to a full-length gene, as well as intein-mediated protein trans-splicing, 57 which reconstitute large proteins from shorter precursor polypeptides (separately encoded by 2 or more independent AAV vectors). Although convincible preclinical data have been generated through subretinal administration, 58 these platforms have not yet been assessed by the SC route.…”
Section: Future Directionsmentioning
confidence: 99%
“…The heterogeneity is developing during the production of an rTP mainly in the upstream processing. The first event increasing the heterogeneity is alternative splicing [17][18][19]. The second critical step is the protein biosynthesis at the ribosomes, in which errors can occur.…”
Section: Analysis Of Proteoforms Of Recombinant Therapeutic Proteins:mentioning
confidence: 99%
“…The unique autocatalytic reaction catalyzed by inteins, which is capable of ligating protein domains, has enabled diverse biotechnological applications of inteins such as protein purification, ligation, and chemical modification . Protein splicing can not only occur in cis but also in trans , through artificially or naturally split inteins, leading to the ligation of individual polypeptides.…”
Section: Figurementioning
confidence: 99%